Interactions between A2A‐adenosine receptors and α2‐, A1‐ and P2‐ release‐inhibitory receptors, on the modulation of noradrenaline release were studied in isolated rat tail artery. Preparations were labelled with [3H]‐noradrenaline, superfused with desipramine‐containing medium, and stimulated electrically (100 pulses at 5 Hz or 20 pulses at 50 Hz).
Blockade of α2‐autoreceptors with yohimbine (1 μM) increased tritium overflow elicited by 100 pulses at 5 Hz but not by 20 pulses at 50 Hz.
The selective A2A‐receptor agonist 2‐p‐(2‐carboxyethyl)phenethylamino‐5′‐N‐ethylcarboxamidoadenosine (CGS 21680; 1 – 100 nM) enhanced tritium overflow elicited by 100 pulses at 5 Hz. Yohimbine prevented the effect of CGS 21680, which was restored by the A1‐receptor agonist N6‐cyclopentyladenosine (CPA; 100 nM) or by the P2‐receptor agonist 2‐methylthioadenosine triphosphate (2‐MeSATP; 80 μM).
CGS 21680 (100 nM) failed to increase tritium overflow elicited by 20 pulses at 50 Hz. The α2‐adrenoceptor agonist 5‐bromo‐6‐(2‐imidazolin‐2‐ylamino)‐quinoxaline (UK 14304; 30 nM), the A1‐receptor agonist CPA (100 nM) or the P2‐receptor agonist 2‐MeSATP (80 μM) reduced tritium overflow. In the presence of these agonists CGS 21680 elicited a facilitation of tritium overflow.
Blockade of potassium channels with tetraethylammonium (TEA; 5 mM) increased tritium overflow elicited by 100 pulses at 5 Hz to values similar to those obtained in the presence of yohimbine but did not prevent the effect of CGS 21680 (100 nM) on tritium overflow.
It is concluded that, in isolated rat tail artery, the facilitation of noradrenaline release mediated by A2A‐adenosine receptors is favoured by activation of release inhibitory receptors.
British Journal of Pharmacology (2002) 136, 230–236; doi: